Electromyoneurography and laboratory findings in a case of Guillain-Barré syndrome after second dose of Pfizer COVID-19 vaccine
Authors:
- 4 August 2021
- journal article
- case report
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 17 (11) , 4093-4096
Abstract
Guillain-Barre syndrome (GBS) is an acute immune-mediated disease of the peripheral nerves and nerve roots (polyradiculoneuropathy) that is usually elicited by various infections. We present a case of GBS after receiving the second dose of Pfizer-COVID 19 vaccine. Diagnosis was made after performing an accurate clinical examination, electromyoneurography and laboratory tests. In particular, anti-ganglioside antibodies have tested positive. During this pandemic with ongoing worldwide mass vaccination campaign, it is critically important for clinicians to rapidly recognize neurological complications or other side effects associated with COVID-19 vaccination.Keywords
Funding Information
- funding agencies in the public, commercial, or not-for-profit sectors
This publication has 10 references indexed in Scilit:
- Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 VaccineCureus, 2021
- Looking beyond COVID-19 vaccine phase 3 trialsNature Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy, MRI Brain and Cerebrospinal Fluid Findings: Case 2Cureus, 2020
- AANEM ‐ IFCN Glossary of Terms in Neuromuscular Electrodiagnostic Medicine and UltrasoundMuscle & Nerve, 2020
- Neurological Complications of Coronavirus Disease (COVID-19): EncephalopathyCureus, 2020
- Drugs and Lactation Database (LactMed)2006
- Anti-ganglioside Antibodies in Guillain-Barré Syndrome; Useful Diagnostic Markers as Well as Possible Pathogenetic FactorsInternal Medicine, 2003
- Peripheral neuropathies and anti-glycolipid antibodiesBrain, 2002
- Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infectionNeurology, 1997